

"A global pharmaceutical company advancing neurology and oncology for patients worldwide"
Eisai is a global pharmaceutical company specialising in prescription medicines for neurology and oncology. Established in 1941 and headquartered in Japan, the company employs over 10,000 people across more than 40 subsidiaries, dedicating resources to diseases where adequate treatments remain scarce, particularly Alzheimer's disease and personalised cancer therapies. The company operates under a human health care philosophy that places patients at the centre of all decisions. This translates into science-based solutions targeting unmet medical needs, initiatives improving medicine access in developing countries, and a commitment to reducing health disparities worldwide.


10917
Team Members
1941
Founded
Pharmaceuticals
Sector
Hybrid
Work Environment
A global environment where everyone can lead healthy lives, free from anxiety over health, with equitable access to treatments that enable people to realize their fullest life from wellness through to the final moments.
Eisai gives first thought to patients and the people in the daily living domain, increasing the benefits that healthcare provides to them and meeting their diverse healthcare needs worldwide.